Sponsor Check › Person
Related person on Form D filings · address states as listed: NJ, CT, MI, GA, PA · listed Jun 10, 2009 → Dec 7, 2016
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 12:10 AM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 24, 2026, 12:10 AM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 12:10 AM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
3 of 18 offerings report sales commissions totalling $6,232,458; 0 report finder's fees; 4 report proceeds to related persons totalling $6,717,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Apr 4, 2022 D File 021-440156 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 17, 2020 D File 021-373368 | $0 | $0 | $0 A portion of the proceeds may be used for general corporate purposes, including to pay salaries of some related persons listed in Item 3. | None listed on this filing |
| EDGAR ↗ | Dec 19, 2019 D File 021-355866 | $1,800,000 | $0 | $0 | Oppenheimer & Co., Inc BrokerCheck CRD 249 ↗ via n/a Ladenburg Thalmann & Co. Inc. BrokerCheck CRD 505 ↗ via n/a Craig-Hallum Capital Group LLC BrokerCheck CRD 121395 ↗ via n/a |
| EDGAR ↗ | Dec 7, 2016 D/A File 021-230865 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 17, 2015 D File 021-241945 | $1,000,000 | $0 | $0 | Livingston Securities, LLC BrokerCheck CRD 147364 ↗ via Livingston Securities, LLC (CRD 147364 ↗) |
| EDGAR ↗ | Sep 30, 2014 D File 021-225512 | $0 (est.) | $0 (est.) | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Sep 23, 2014 D/A File 021-91597 | $0 (est.) | $0 (est.) | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jul 15, 2014 D File 021-221046 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 9, 2013 D/A File 021-188532 | $0 | $0 | $1,000,000 (est.) | None listed on this filing |
| EDGAR ↗ | May 13, 2013 D/A File 021-183445 | $3,432,458 | $0 | $4,000,000 (est.) Represents estimated salary payments over a period of 48 months. | National Securities Corporation BrokerCheck CRD 7569 ↗ Roth Capital Partners, LLC BrokerCheck CRD 15407 ↗ |
| EDGAR ↗ | Apr 26, 2013 D File 021-195652 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 28, 2011 D File 021-170796 | $0 | $0 | $450,000 (est.) | None listed on this filing |
| EDGAR ↗ | Feb 11, 2011 D/A File 021-118048 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 7, 2010 D File 021-147373 | $0 | $0 | $1,267,000 (est.) | None listed on this filing |
| EDGAR ↗ | May 10, 2010 D File 021-141795 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 18, 2009 D File 021-132078 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 10, 2009 D File 021-131856 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 22, 2009 D File 021-59654 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | MARINUS PHARMACEUTICALS, INC. | Director Director, Chairman of the Board | Apr 4, 2022 | D | $1,230,085 similar: $1,694,259–$16,000,000 | $1,230,085 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Antios Therapeutics Inc. | Director | Aug 17, 2020 | D | $5,000,000 similar: $2,000,000–$19,999,994 | $4,399,999 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | MARINUS PHARMACEUTICALS, INC. | Director | Dec 19, 2019 | D | $30,000,000 similar: $1,694,259–$16,000,000 | $30,000,000 | 4 similar: 1–13 | $4,625,000 similar: $10,000–$55,000 |
| EDGAR ↗ | Domain Partners IX, L.P. group: Domain | Executive Officer | Dec 7, 2016 | D/A | Indefinite similar: $155,000–$5,250,000 | $163,636,363 | 6 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Domain Partners IX, L.P. group: Domain | Executive Officer | Dec 3, 2015 | D/A | Indefinite similar: $155,000–$5,250,000 | $163,636,363 | 6 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Celtaxsys, Inc. | Director | Jun 17, 2015 | D | $40,003,981 similar: $2,000,000–$19,999,994 | $21,628,985 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Domain Partners IX, L.P. group: Domain | Executive Officer | Dec 24, 2014 | D | Indefinite similar: $155,000–$5,250,000 | $163,636,363 | 6 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | VentiRx Pharmaceuticals Inc. | Director | Sep 30, 2014 | D | $15,000,000 similar: $2,000,000–$19,999,994 | $15,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | VentiRx Pharmaceuticals Inc. | Director | Sep 23, 2014 | D/A | $53,102,414 similar: $2,000,000–$19,999,994 | $50,602,514 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Esperion Therapeutics, Inc. | Director | Jul 15, 2014 | D | Indefinite similar: $1,694,259–$16,000,000 | $0 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | MARINUS PHARMACEUTICALS, INC. | Director | Jul 9, 2013 | D/A | $22,272,848 | $21,772,848 | 7 | No minimum reported |
| EDGAR ↗ | Celator Pharmaceuticals Inc | Director | May 13, 2013 | D/A | $39,262,788 | $39,262,788 | 306 | $22,500 |
| EDGAR ↗ | Esperion Therapeutics, Inc. | Director | Apr 26, 2013 | D | Indefinite | $17,000,000 | 10 | No minimum reported |
| EDGAR ↗ | MARINUS PHARMACEUTICALS, INC. | Director | Dec 18, 2012 | D | $21,228,487 | $11,435,690 | 6 | No minimum reported |
| EDGAR ↗ | Celator Pharmaceuticals Inc | Director | Aug 30, 2012 | D | $35,000,000 | $4,148,617 | 106 | $22,500 |
| EDGAR ↗ | VentiRx Pharmaceuticals Inc. | Director | Mar 8, 2012 | D/A | $25,000,002 | $18,750,001 | 5 | No minimum reported |
| EDGAR ↗ | Celator Pharmaceuticals Inc | Director | Dec 28, 2011 | D | $5,000,500 | $2,576,867 | 10 | No minimum reported |
| EDGAR ↗ | Esperion Therapeutics, Inc. | Director | Feb 11, 2011 | D/A | $38,760,000 | $27,950,000 | 9 | No minimum reported |
| EDGAR ↗ | Celator Pharmaceuticals Inc | Director | Sep 7, 2010 | D | $20,000,003 | $15,000,001 | 12 | No minimum reported |
| EDGAR ↗ | Celator Pharmaceuticals Inc | Director | May 10, 2010 | D | $2,500,000 | $2,500,000 | 9 | No minimum reported |
| EDGAR ↗ | Esperion Therapeutics, Inc. | Director | Feb 12, 2010 | D/A | $38,250,000 | $27,750,000 | 7 | No minimum reported |
| EDGAR ↗ | VentiRx Pharmaceuticals Inc. | Director | Jan 22, 2010 | D | $25,000,002 | $12,500,001 | 5 | $1 |
| EDGAR ↗ | Domain Partners VIII, L.P. group: Domain | Executive Officer | Jun 18, 2009 | D | Indefinite | $371,070,000 | 32 | $5,000,000 |
| EDGAR ↗ | DP VIII Associates, L.P. group: Domain | Executive Officer | Jun 10, 2009 | D | Indefinite | $3,673,000 | 35 | $50,000 |
| EDGAR ↗ | MARINUS PHARMACEUTICALS, INC. | Director | Apr 22, 2009 | D | Indefinite | $20,411,559 | 7 | No minimum reported |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); Biotechnology / 506(b) (3,253 filings); Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Nicole Vitullo. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Nicole Vitullo appears on a new Form D, or when a court case or SEC action is matched to them. See plans →